Literature DB >> 22083900

Metabolites of the mangrove fungus Xylaria sp. BL321 from the South China Sea.

Yong-Xiang Song1, Jun Wang, Shi-Wu Li, Bin Cheng, Li Li, Bin Chen, Lan Liu, Yong-Cheng Lin, Yu-Cheng Gu.   

Abstract

Two new lactones, 1 and 2, together with five known compounds, 3-7, were isolated from the marine mangrove fungus Xylaria sp. BL321. Their structures were determined by comprehensive analysis of their MS and NMR spectroscopic data. The absolute configurations of 1 and 2 were established on the basis of electronic circular dichroism calculations. It was found that the exocyclic double bond of 1 rearranged into a cyclic double bond to form a new crystal compound (1a) in diluted NaOH solution. Compound 3 was isolated for the first time as a natural product; its absolute configuration was determined by single-crystal X-ray crystallography. Compounds 4-7 displayed cytotoxicity against human breast cancer cell lines MCF-7 and MDA-MB-435, while compounds 1- 3 were inactive (IC(50) > 50 µM). © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22083900     DOI: 10.1055/s-0031-1280347

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  3 in total

1.  Four eremophilane sesquiterpenes from the mangrove endophytic fungus Xylaria sp. BL321.

Authors:  Yongxiang Song; Jiajian Wang; Hongbo Huang; Lin Ma; Jun Wang; Yucheng Gu; Lan Liu; Yongcheng Lin
Journal:  Mar Drugs       Date:  2012-02-06       Impact factor: 6.085

2.  Isobenzofuranones and Isochromenones from the Deep-Sea Derived Fungus Leptosphaeria sp. SCSIO 41005.

Authors:  Xiaowei Luo; Xiuping Lin; Limbadri Salendra; Xiaoyan Pang; Yu Dai; Bin Yang; Juan Liu; Junfeng Wang; Xuefeng Zhou; Yonghong Liu
Journal:  Mar Drugs       Date:  2017-06-29       Impact factor: 5.118

3.  Secondary metabolites from the endolichenic fungus Ophiosphaerella korrae.

Authors:  Yue-Lan Li; Rong-Xiu Zhu; Gang Li; Ning-Ning Wang; Chun-Yu Liu; Zun-Tian Zhao; Hong-Xiang Lou
Journal:  RSC Adv       Date:  2019-01-31       Impact factor: 3.361

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.